Thyrocare Technologies has informed about appointment of Rahul Guha as Managing Director and Chief Executive Officer of the company with effective from 04-May-2022. Rahul Guha will also function as the Managing Director & CEO of Nueclear Healthcare, its wholly owned subsidiary. Dharmil Sheth, who was appointed as the Managing Director for the interim period to comply with the provisions of Sec. 203 (4) of the Companies Act, 2013, has demitted office effective from Wednesday, May 04, 2022 and will continue to be a Non-Executive, Non-Independent Director of the Company.
The above information is a part of company’s filings submitted to BSE.
